Pure Bioscience, Inc. (PURE) Reports Q4 Loss of $0.01
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 subdued as gains in banks offset AI jitters; Dow at one-month high
- Oil heads for weekly gain with focus on Middle East supply
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
Tweet
Share
E-mailGet Alerts PURE Hot Sheet
Price: $0.07 --0%
Financial Fact:
Research and development: 248K
Today's EPS Names:
OMID, BCBP, BCML, More
Financial Fact:
Research and development: 248K
Today's EPS Names:
OMID, BCBP, BCML, More
Join SI Premium – FREE
Pure Bioscience, Inc. (OTC: PURE) reported Q4 EPS of ($0.01). Revenue for the quarter came in at $391 thousand.
For earnings history and earnings-related data on Pure Bioscience, Inc. (PURE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Two Sigma halts real estate unit fundraising and cuts staff - Bloomberg
- Ladder Capital (LADR) Tops Q3 EPS by 24c
- Cogent Communication (CCOI) said to utilize Evercore amid financing issues
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
